A recent study on Hodgkin’s disease and anaplastic large cell lymphoma reported that tumor cells may aberrantly express TNF-α or thymus- and activation-regulated chemokines (TARC), which might attract a specific lymphocytic subset and CD4 + T-cell with a Th2 phenotype in particular (16). The gene discussed is CCL17; the disease is neoplasm.